Génétique HumaineJean de Grouchy, Francis John Govier Ebling, I. W. Henderson Excerpta Medica, 1972 - 499 Seiten |
Im Buch
Ergebnisse 1-3 von 84
Seite 11
... example , the number of recognized hereditary aminoacidopathies and G6PD mutants has increased steadily in the past two decades ( Fig . 2 ) because of available technology , mass screening and expanding interest in such problems . These ...
... example , the number of recognized hereditary aminoacidopathies and G6PD mutants has increased steadily in the past two decades ( Fig . 2 ) because of available technology , mass screening and expanding interest in such problems . These ...
Seite 209
... example , a D to G chromosome . Such an observation which has , as far as I am aware , not yet been made , would certainly be in favour of the hypothesis . Also , if the crossing - over were unequal , there could be duplication or ...
... example , a D to G chromosome . Such an observation which has , as far as I am aware , not yet been made , would certainly be in favour of the hypothesis . Also , if the crossing - over were unequal , there could be duplication or ...
Seite 301
... example , removal of amide groups from asparagine or glutamine residues , oxidation of reactive sulphydryl groups on cysteine residues , addition of phosphate groups or carbohydrate side chains , partial degradation due to cleavage by ...
... example , removal of amide groups from asparagine or glutamine residues , oxidation of reactive sulphydryl groups on cysteine residues , addition of phosphate groups or carbohydrate side chains , partial degradation due to cleavage by ...
Inhalt
Clinical geneticsGénétique clinique | 25 |
Radiation geneticsRadiations ionisantes | 38 |
Données récentes sur les taux de mutations radioinduites chez | 67 |
Urheberrecht | |
17 weitere Abschnitte werden nicht angezeigt.
Häufige Begriffe und Wortgruppen
abnormal Acad acid activity alleles analysis aneuploid anti anticoagulant anticorps antigen antipyrine autosomal biochemical bishydroxycoumarin blood cell hybrids cell lines chimerism clinical clones culture Cytogenetics deficiency dehydrogenase detected deux diagnosis dose drug metabolism effect electrophoretic enzyme assay estimate été être factors Fagerhol female fibroblasts fraction G6PD gamètes gène genetic genetic control génétique hereditary heterozygotes heterozygous hexosaminidase HL-A human chromosomes individuals inheritance isozymes karyotype Level linkage lipoprotein loci locus Lp(a Lp(a+ lymphocytes lymphoid cell male marker meiosis meiotic mental retardation mouse mutation Nature Lond Negro normal observed pairs parents patients patterns peut pharmacogenetics phenotype phenylbutazone plasma polymorphism population possible Proc produit propositus protein prothrombin Pygmies rearrangement recombination red cells sera serum sibship singletons somatic cell structure studies syndrome Table Tay-Sachs disease tests tion tissues translocations twins variants Vesell vitamin vitamin K warfarin X chromosome XX/XY